Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Soleno Therapeutics, Inc.
Age
4–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Provide voluntary, written informed consent (parent(s) / legal guardian(s) of patient); provide voluntary, written assent (patients, as appropriate)
Genetically-confirmed Prader-Willi syndrome and hyperphagic
In a stable care setting for at least 6 months prior to Visit 1
Caregiver must have been caring for the patient for at least 6 months prior to Visit 1
You may not be if
Have participated in an interventional clinical study (i.e., investigational drug or device, approved drugs or device evaluated for unapproved use) within prior 3 months
Positive urine pregnancy test (in females of child-bearing potential) or females who are pregnant or breastfeeding, and/or plan to become pregnant or to breast-feed during or within 30 days after study participation
Any other known disease and/or condition, which would prevent, in the opinion of the Investigator, the patient from completing all study visits and assessments required by the protocol
Clareo Health | A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome
